Back to search
FDAFDA · Food and drugs·Recall number D-0998-2020

Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01

Published March 18, 2020 · Recall initiated: March 2, 2020

Summary

FDA records drug Class II recall D-0998-2020, published March 18, 2020 and initiated March 2, 2020. Recalling firm: Mayne Pharma Inc; Status: Terminated; Reported quantity: 8274 100-count bottles; Lot: Lot: FG11514 Exp. 05/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product Mix-Up: A foreign tablet was found in bottle.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mayne Pharma Inc
Distributor
Distributed Nationwide in the USA
Lot
Lot: FG11514 Exp. 05/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01 recalled?

Yes. FDA published recall D-0998-2020 on March 18, 2020. Reported hazard: Product Mix-Up: A foreign tablet was found in bottle.

What should I do if I have this product?

Voluntary: Firm initiated · Letter